Oxnard, California, October 5th, 2020
FOMAT Medical Research, is a company focused on the pharmaceutical industry, based in Oxnard, California, and has over 10 years of experience in developing clinical trials throughout all phases. Currently, the company is a member of HyperCORE International, and has been selected as a leading company within the industry to participate in clinical trials to help find a potential treatment or vaccine to treat or prevent coronavirus 2 (SARS-CoV-2), which was declared as a pandemic by the World Health Organization (WHO) in March.
The Company was awarded “Innovative business of the Year” by the Oxnard Chamber of Commerce due to the work we have carried out at our headquarters. FOMAT, from their facilities, offers the community the opportunity to do a free test to detect COVID-19. Through this study, Nicholas Focil, CEO of FOMAT, wants to not only provide to the community a possibility to diagnose the disease but to help find something that will prevent or treat the coronavirus. Nicholas also ensures that the inclusion of “minorities” in the trials would help with data for future treatments.
The Oxnard Chamber of Commerce is the catalyst for business growth, the conveyor of leaders and influencers, and the advocate for the Oxnard community. Its mission is to represent the interests of business and advocate for public policy that promotes a healthy economy. Founded in 1908, the Chamber today empowers 500 enterprises and organizations that employ more than 30,000 people.
About FOMAT Medical Research:
FOMAT Medical Research is an Integrated Research Organization (IRO), or also known as a Site Management Organization (SMO), focused on innovating healthcare throughout the Americas. With over 10 years of experience in participating in Phase 1 through Phase 4 clinical trials in a wide variety of therapeutic areas, we rely on a highly experienced clinical research team that has the professional expertise necessary to assist Sponsors and Contract Research Organizations (CRO) with reaching their project goals quickly and effectively.
Our mission is to diversify clinical trials throughout the Americas and innovating healthcare for underrepresented populations while ensuring that we uphold Good Clinical Practice standards and ethics are upheld. We find itIt is essential that high-quality data is contributed to the scientific community to create better treatments.